Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic-pharmacodynamic study. [electronic resource]
- British journal of clinical pharmacology Nov 2007
- 622-33 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0306-5251
10.1111/j.1365-2125.2007.02956.x doi
Adult Aged Antineoplastic Agents, Phytogenic--adverse effects Bilirubin--blood Biomarkers--blood Cohort Studies Dose-Response Relationship, Drug Female Humans Liver Diseases--complications Liver Function Tests--methods Male Middle Aged Paclitaxel--adverse effects Sex Factors Treatment Outcome